Free Newsletter
Euro watchdogs: Sanofi obstructed probe
Apparently it's an antitrust kind of day: The European Commission announced it's investigating Sanofi-Aventis for obstructing its big probe of anticompetitive tactics in the drug industry. Europe's antitrust watchdog was raiding Sanofi's HQ in France when company officials refused to release documents without a search warrant from the French government. European law, however, requires companies to comply with E.C. inspectors.
You'll recall that in January, the E.C.'s antitrust cops raided a number of drugmakers in January, looking for evidence that their behavior in patenting new drugs and suing generics makers may have dampened competition.
- see the E.C.'s release
- get the Dow Jones story for more
Related Articles:
EU commissioner widens pharma probe
EC launches pharma antitrust probe
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: